|
Name |
Fusariumester D
|
Molecular Formula | C36H58O10 | |
IUPAC Name* |
14-(14-carboxy-3-hydroxy-2,8,10,12-tetramethyltetradeca-10,12-dienoyl)oxy-13-hydroxy-3,5,7-trimethylpentadeca-2,4-dienedioicacid
|
|
SMILES |
CC(=CC(=O)O)C=C(C)CC(C)CCCCC(O)C(C)C(=O)OCC(C(=O)O)C(O)CCCCC(C)CC(C)=CC(C)=CC(=O)O
|
|
InChI |
InChI=1S/C36H58O10/c1-23(16-25(3)18-27(5)20-33(39)40)12-8-10-14-31(37)29(7)36(45)46-22-30(35(43)44)32(38)15-11-9-13-24(2)17-26(4)19-28(6)21-34(41)42/h18-21,23-24,29-32,37-38H,8-17,22H2,1-7H3,(H,39,40)(H,41,42)(H,43,44)/b25-18+,26-19+,27-20+,28-21+/t23-,24-,29+,30+,31-,32-/m1/s1
|
|
InChIKey |
NHGMOYQLUWRLJI-SPEWQSESSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 650.85 | ALogp: | 6.7 |
HBD: | 5 | HBA: | 7 |
Rotatable Bonds: | 24 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 178.7 | Aromatic Rings: | 0 |
Heavy Atoms: | 46 | QED Weighted: | 0.033 |
Caco-2 Permeability: | -5.871 | MDCK Permeability: | 0.00000629 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.977 |
Human Intestinal Absorption (HIA): | 0.985 | 20% Bioavailability (F20%): | 0.439 |
30% Bioavailability (F30%): | 0.781 |
Blood-Brain-Barrier Penetration (BBB): | 0.024 | Plasma Protein Binding (PPB): | 92.99% |
Volume Distribution (VD): | 0.414 | Fu: | 2.09% |
CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.091 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.06 |
CYP2C9-inhibitor: | 0.169 | CYP2C9-substrate: | 0.988 |
CYP2D6-inhibitor: | 0.062 | CYP2D6-substrate: | 0.115 |
CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.014 |
Clearance (CL): | 1.159 | Half-life (T1/2): | 0.937 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.89 |
Drug-inuced Liver Injury (DILI): | 0.495 | AMES Toxicity: | 0.001 |
Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.352 |
Skin Sensitization: | 0.971 | Carcinogencity: | 0.165 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.018 |
Respiratory Toxicity: | 0.094 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005665 | 0.885 | D0D9NY | 0.233 | ||||
ENC005667 | 0.848 | D0X4FM | 0.231 | ||||
ENC005668 | 0.781 | D0TP2W | 0.230 | ||||
ENC005669 | 0.544 | D03JSJ | 0.225 | ||||
ENC005670 | 0.468 | D00FSV | 0.224 | ||||
ENC006085 | 0.352 | D0C3LP | 0.209 | ||||
ENC001858 | 0.305 | D0RQ2W | 0.204 | ||||
ENC001412 | 0.299 | D0ZI4H | 0.204 | ||||
ENC001818 | 0.299 | D0N3NO | 0.202 | ||||
ENC005267 | 0.273 | D09XWD | 0.199 |